...
首页> 外文期刊>Circulation journal >Contemporary Antiplatelet Therapy and Clinical Outcomes of Japanese Patients With Acute Myocardial Infarction Results From the Prospective Japan Acute Myocardial Infarction Registry (JAMIR)
【24h】

Contemporary Antiplatelet Therapy and Clinical Outcomes of Japanese Patients With Acute Myocardial Infarction Results From the Prospective Japan Acute Myocardial Infarction Registry (JAMIR)

机译:当代抗血小板治疗和日本症患者急性心肌梗塞患者的临床结果来自前瞻性日本急性心肌梗死登记处(JAMIR)

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Antiplatelet therapy is the corner stone of treatment following acute myocardial infarction (AMI). Prasugrel, a new and potent antiplatelet agent, was recently introduced to clinical practice. We compared the clinical outcomes of patients with AMI treated with prasugrel with those treated with clopidogrel in real-world clinical practice in Japan.
机译:背景:抗血小板疗法是急性心肌梗死(AMI)后治疗的角落。 最近推出了普拉布雷,一种新的和有效的抗血小板剂,临床实践。 我们将患有普拉布雷治疗的AMI患者的临床结果与日本现实世界临床实践中的氯吡格雷治疗治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号